CLDN14: A Potential Drug Target Or Biomarker (G23562)
CLDN14: A Potential Drug Target Or Biomarker
CLDN14 (CLD14_HUMAN), a gene encoding a protein known asCLDN14, has been identified as a potential drug target or biomarker for various diseases, including cancer, heart disease, and neurodegenerative disorders.
CLDN14 is a transmembrane protein that is expressed in various tissues and organs, including the brain, pancreas, and blood vessels. It is known to be involved in the regulation of water and electrolyte balance, and has been implicated in various physiological processes, including blood pressure, immune response, and neurotransmission.
Recent studies have suggested that CLDN14 may be a drug target or biomarker for various diseases, including cancer, heart disease, and neurodegenerative disorders. For example, CLDN14 has been shown to be overexpressed in various types of cancer, and may be a useful target for cancer therapies. Additionally, CLDN14 has been shown to be involved in the regulation of heart function, and may be a useful biomarker for heart disease.
Another study found that CLDN14 was overexpressed in the brains of individuals with neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. This suggests that CLDN14 may be a useful target for neurodegenerative disorders.
In addition to its potential as a drug target or biomarker, CLDN14 is also a potential biomarker for certain diseases. For example, CLDN14 has been shown to be elevated in the blood of individuals with heart disease, and may be a useful biomarker for heart disease. Additionally, CLDN14 has been shown to be elevated in the urine of individuals with certain types of cancer, and may be a useful biomarker for cancer.
Overall, CLDN14 is a protein that has potential as a drug target or biomarker for various diseases. Further research is needed to fully understand its role and potential as a drug.
Protein Name: Claudin 14
Functions: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity
More Common Targets
CLDN14-AS1 | CLDN15 | CLDN16 | CLDN17 | CLDN18 | CLDN19 | CLDN2 | CLDN20 | CLDN22 | CLDN23 | CLDN24 | CLDN25 | CLDN3 | CLDN34 | CLDN4 | CLDN5 | CLDN6 | CLDN7 | CLDN8 | CLDN9 | CLDND1 | CLDND2 | Cleavage and polyadenylation specificity factor complex | Cleavage factor Im complex | Cleavage Stimulation Factor | CLEC10A | CLEC11A | CLEC12A | CLEC12A-AS1 | CLEC12B | CLEC14A | CLEC16A | CLEC17A | CLEC18A | CLEC18B | CLEC18C | CLEC19A | CLEC1A | CLEC1B | CLEC2A | CLEC2B | CLEC2D | CLEC2L | CLEC3A | CLEC3B | CLEC4A | CLEC4C | CLEC4D | CLEC4E | CLEC4F | CLEC4G | CLEC4GP1 | CLEC4M | CLEC4OP | CLEC5A | CLEC6A | CLEC7A | CLEC9A | CLECL1P | CLGN | CLHC1 | CLIC1 | CLIC1P1 | CLIC2 | CLIC3 | CLIC4 | CLIC5 | CLIC6 | CLINT1 | CLIP1 | CLIP1-AS1 | CLIP2 | CLIP3 | CLIP4 | CLK1 | CLK2 | CLK2P1 | CLK3 | CLK4 | CLLU1 | CLLU1-AS1 | CLMAT3 | CLMN | CLMP | CLN3 | CLN5 | CLN6 | CLN8 | CLNK | CLNS1A | CLOCK | CLP1 | CLPB | CLPP | CLPS | CLPSL1 | CLPSL2 | CLPTM1 | CLPTM1L | CLPX